Abstract
Aim: To determine whether increased vitamin D testing resulted in improved osteoporosis detection in Australian females aged 45–74 yr. Methods: Longitudinal analysis of bone densitometry, 25-hydroxyvitamin D (25(OH)D) and full blood count (FBC) testing between 2001 and 2011. The number and rate of tests per 100,000 individuals and benefit in dollars for bone densitometry, 25(OH)D and FBC from 2001–2011 for individuals aged 45–74 yr were obtained from Medicare Australia. Results: There was a disproportionate increase in 25(OH)D testing compared to bone density testing from 2001 to 2011, whereby 25(OH)D testing increased from 26,666 to 1.65 million p.a. and bone density testing increased from 41,453 to 66,100 p.a. Bone densitometry increased approximately 1.2 fold, whereas 25(OH)D testing increased by 55.2,41.2 and 34.3 fold in females aged 45–54, 55–64 and 65–74 yr, respectively. This represents an increase in annual benefits from approximately $2.5–$4.1 million for bone density testing and $0.7–$40.5 million for 25(OH)D testing over the period. Conclusions: This study demonstrates that improved detection of vitamin D deficiency is not being translated into better detection in at-risk women of the consequences of vitamin D deficiency on target organs such as bone. This failure to translate rising awareness and better detection of vitamin D deficiency into physiological outcomes is a massive missed opportunity for improved bone health and reduced fracture risk. We propose that clinical practice guidelines be introduced not only for the purpose of diagnosis and testing for vitamin D, but to include recommendations for bone health testing in at-risk individuals.
Similar content being viewed by others
References
Kanis J. WHO Technical Report, University of Sheffield, UK, 2007.
Sambrook PN, Seeman E, Phillips SR, et al. Preventing osteoporosis: outcomes of the Australian Fracture Prevention Summit. Med J Aust 2002, 176 (Suppl): S1–16.
International Osteoporosis Foundation [Internet]. [Accessed 22 June 2012] Available at: http://www.iofbonehealth.org/bonehealth/
Berger C, Joseph L, Hanley DA, et al. Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. Can Med Assoc J 2008, 178: 1660–8.
Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995, 332: 767–73.
Kota SK, Kota SK, Krishna SVS, Meher LK, Modi KD. Relation of vitamin D levels with bone mineral density and parathyroid hormone in adults with low bone density. Endocr Rev 2012, 33: (03 Meeting Abstracts) SAT–359.
Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003, 112: e132–5.
Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007, 24: 1017–29.
Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367: 40–9.
Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357: 266–81.
Bilinski K, Boyages S. The rising cost of vitamin D testing in Australia: Time to establish guidelines for testing. Med J Aust 2012, 197: 90.
Bilinski K, Boyages S. Preventing overdiagnosis: the rise and rise of Vitamin D testing. BMJ 2012, 345: e4743.
MBS Online. Medicare Benefits Schedule, ed. July 2011, Australian Government. Department of Health and Aging, 2011.
Rosen CJ, Adams JS, Bikle DD, et al. The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific Statement. Endocr Rev 2012, 33: 456–92.
Boyages S, Bilinski K. Seasonal reduction in vitamin D level persists into spring in NSW Australia: implications for monitoring and replacement therapy. Clin Endocrinol (Oxf) 2012, 77: 515–23.
Lewiecki EM. Update on bone density testing. Curr Osteoporos Rep 2005, 3: 136–42.
Lewiecki EM, Laster AJ, Miller PD, et al. More bone density testing is needed, not less. J Bone Miner Res 2012, 27: 739–42.
Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. South Melbourne, Victoria: The Royal Australian College of General Practitioners, 2010.
Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012, 344: e3502.
Author information
Authors and Affiliations
Corresponding author
Additional information
K.B. and S.B. share the co-authorship of this article.
Rights and permissions
About this article
Cite this article
Bilinski, K., Boyages, S. The Vitamin D paradox: Bone density testing in females aged 45 to 74 did not increase over a ten-year period despite a marked increase in testing for vitamin D. J Endocrinol Invest 36, 914–922 (2013). https://doi.org/10.3275/8922
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3275/8922